Kadena Hitoshi | Hiroshima University School of Medicine
スポンサーリンク
概要
関連著者
-
Usui T
Hiroshima Univ. Hiroshima Jpn
-
Igawa M
Department Of Urology Shimane University School Of Medicine
-
Kadena Hitoshi
Hiroshima University School of Medicine
-
Shiina Hiroaki
Shimane University
-
Igawa Mikio
Shimane University
-
Shirakawa Hiroki
Department Of Urology Shimane University School Of Medicine
-
Ishibe Tomoyuki
Shimane Medical University
-
IGAWA Mikio
Department of Urology, Shimane University School of Medicine
-
Igawa Mikio
Department Of Urology Shimane Medical University
-
USUI TSUGURU
Department of Urology, Hiroshima University
-
Honda Satoshi
Gunma Astronomical Observatory Gunma
-
Nakamoto Takahisa
Department Of Urology Hiroshima University School Of Medicine
-
Usui Tsuguru
Department Of Urology Hiroshima University Graduate School Of Biomedical Sciences
-
Urakami Shinji
Department Of Urology Shimane University School Of Medicine
-
Yoneda Tatsuaki
Shimane University School of Medicine
-
Urakami Shinji
Shimane Medical University
-
Shirakawa Hiroki
Shimane Medical University
-
Usui Tsuguru
Hiroshima University School of Medicine
-
Honda Satoshi
Shimane Medical University
-
Nakamoto Takahisa
Hiroshima University School of Medicine
-
UEDA Mitsutaka
Department of Urology, Hiroshima University School of Medicine
-
KADENA Hitoshi
Department of Urology, Hiroshima University School of Medicine
-
Yoneda Tatsuaki
Department Of Urology Shimane University School Of Medicine
-
Ueda Mitsutaka
Department Of Urology Hiroshima General Hospital
-
HONDA Satoshi
Kwasan Observatory, Graduate School of Science, Kyoto University
-
Honda Satoshi
Kwasan Observatory Graduate School Of Science Kyoto University
-
Honda Satoshi
Kwasan Observatory Kyoto University
著作論文
- Collecting duct carcinoma of the kidney : a case report
- Neoadjuvant chemotherapy and bladder preservation for invasive bladder cancer
- M-VEC (METHOTREXATE, VINBLASTLNE, 4'-EPIRUBICIN AND CISPLATIN) COMBINED WITH GLYCOSYLATED RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR (rhG-CSF) FOR THE TREATMENT OF TRANSITIONAL CELL CARCINOMA OF UROTHELIUM : REDUCTION IN TOXICITY PRODUCED BY